Co-Diagnostics Holders Approve Reverse-Split Authority, Warrant Exercise and 2M-Share Plan Increase
CODX is trading near its 52-week low of $0.245 (5.7% above the low) on light trading volume (0.3× avg).
Summary
Co-Diagnostics shareholders approved all nine proposals at the November 13 special meeting, including reverse-split authority up to 1-for-750, issuance of conversion shares under the secured convertible notes, and a 2,000,000-share increase to the 2025 equity plan reserve.
Key Events · Corporate Governance and Compliance · CODX
-
All Nine Proposals Approved
The court-ordered special meeting achieved quorum and passed every proposal, including director elections, the equity plan increase, warrant exercise, note conversion shares and reverse-split authority.
-
Reverse Split Authority Up to 1-for-750
Proposal No. 8 passed 2,742,151 to 940,861, letting the Board effect one or more reverse splits at not less than 1-for-2 with a cumulative effect not exceeding 1-for-750 within twelve months.
-
Note Conversion Shares Cleared
Proposal No. 7 approving issuance of shares upon conversion of the secured convertible notes passed narrowly: 546,401 for, 442,538 against and 605,743 abstentions.
-
Equity Plan Reserve Raised 2,000,000 Shares
The Plan Amendment lifts the 2025 Equity Incentive Plan maximum to 2,223,333 shares, effective on shareholder approval November 13, 2026.
Analysis · CODX · Industrial Applications And Services
The court-ordered special meeting finally produced a quorum and passed every proposal, clearing the governance logjam that had blocked four prior meetings. Most consequential are the authority for one or more reverse splits up to a cumulative 1-for-750 and the green light to issue shares on conversion of the J.J. Astor secured convertible notes — the financing that already diverts ATM proceeds to the lender. Holders also approved potential exercise of 3,404,724 warrants at $1.56, roughly six times today's $0.2585 share price, so those warrants are unlikely to be exercised unless the stock is re-rated. The 2,000,000-share increase in the equity plan reserve is small in absolute terms but adds further overhang to a company that ended Q3 with $714,803 of cash and going-concern doubt.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CODX was trading at $0.26 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.7M. The 52-week trading range was $0.24 to $13.54. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.